Editas Medicine stockholders elect Class II directors, approve say-on-pay, ratify auditor

Editas Medicine, Inc.

Elected Meeta Chatterjee, Andrew Hirsch, Gilmore O'Neill as Class II directors for term until 2027 annual meeting.
Advisory say-on-pay approved with 38,609,828 votes for, 2,769,887 against, 205,788 abstentions.
Ratified Ernst & Young as independent auditor for fiscal 2024 with 57,952,408 votes for, 362,117 against, 1,036,297 abstentions.
Broker non-votes of 17,765,319 on director election and say-on-pay; none on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.